Madrigal Pharmaceuticals, Inc.
MDGL
$425.85
-$9.77-2.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.19% | 11.13% | -24.65% | -20.39% | 46.07% |
| Total Receivables | 149.85% | 271.88% | 1,048.44% | -- | -- |
| Inventory | 119.68% | 695.38% | 797.86% | 6,368.50% | -- |
| Prepaid Expenses | 246.76% | 136.47% | 291.66% | 65.60% | 337.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.80% | 0.00% | 0.00% | -- | -- |
| Total Current Assets | 20.61% | 26.61% | -8.09% | -8.01% | 62.08% |
|
|
|||||
| Total Current Assets | 20.61% | 26.61% | -8.09% | -8.01% | 62.08% |
| Net Property, Plant & Equipment | 40.23% | 73.64% | 137.29% | 20.52% | 40.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.08% | 55.16% | -7.37% | -7.22% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 20.85% | 26.95% | -7.67% | -7.91% | 62.71% |
|
|
|||||
| Total Accounts Payable | 12.11% | -2.23% | 322.23% | 95.35% | 55.48% |
| Total Accrued Expenses | 108.82% | 163.64% | 36.21% | 34.57% | 38.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.56% | 23.35% | 88.33% | 87.45% | 86.53% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 83.30% | 120.08% | 57.00% | 46.26% | 42.79% |
|
|
|||||
| Total Current Liabilities | 83.30% | 120.08% | 57.00% | 46.26% | 42.79% |
| Long-Term Debt | 189.09% | 190.17% | 1.52% | 1.61% | 1.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 561.20% | 373.30% | 402.67% | -28.23% | -14.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 128.20% | 148.80% | 31.62% | 23.53% | 22.38% |
|
|
|||||
| Common Stock & APIC | 5.33% | 5.48% | 4.78% | 10.75% | 46.80% |
| Retained Earnings | -16.00% | -16.59% | -17.23% | -26.39% | -34.86% |
| Treasury Stock & Other | 86.54% | -15.97% | 401.90% | 326.16% | 0.00% |
| Total Common Equity | -20.11% | -19.48% | -18.80% | -16.47% | 86.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.11% | -19.48% | -18.80% | -16.47% | 86.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.11% | -19.48% | -18.80% | -16.47% | 86.11% |
|
|
|||||